Two Patients With Non-Hodgkin Waldenstrom Lymphoma See Complete Responses With CD19 CAR-NK Immunotherapy, ImmunityBio Reports
Written by
American Journal Managed Care
Published
0
comments
0
min
ImmunityBio's study reveals promising results for chemotherapy-free CD19 CAR NK cell therapy in treating Waldenström macroglobulinemia, offering hope for patients.